Food Allergy Market Worth USD 3 Billion Across the 7MM, Anticipated to Grow at a CAGR of 11.3% by 2034 | DelveInsight
The food allergy market is projected to experience significant growth in the coming years, driven by the adoption of recently approved therapies and promising emerging treatments such as Viaskin (DBV712) Peanut Patch (DBV Technologies), PVX108 (Aravax), Remibrutinib (Novartis), SLIT tablet (ALK-Abello), RPT904
